PCLO PharmaCielo Ltd.

0.0245USD0.0350 CAD · TSXV-22.22%Mkt Cap: 5.41M USDP/E: —

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetra…

Institutional holders2 on file

Key Statistics

Company
Market Cap5.41M USD
Enterprise Value18.09M USD
Revenue (TTM)2.52M USD
Gross Profit507.12K USD
Net Income (TTM)-2.50M USD
Revenue/Share0.01 USD
Last Price0.0245 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA71716K1012
Valuation
P/E (Trailing)—
P/E (Forward)-0.70
PEG—
EV/EBITDA-13.56
EV/Revenue7.18
P/S2.15
P/B-0.69
EPS (TTM)-0.01 USD
EPS (Forward)-0.03 USD
52W Range
0.02450% of range0.1154
52W High0.1154 USD
52W Low0.0245 USD
Profitability
Gross Margin28.59%
Oper. Margin-86.73%
EBITDA Margin-52.93%
Profit Margin-141.06%
ROE32.58%
ROA-28.47%
ROIC-46.67%
ROCE—
Growth
Revenue Growth331.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.23M USD
CapEx (TTM)—
FCF Margin-152.35%
FCF Yield-70.98%
Net Debt12.68M USD
Net Debt/EBITDA-9.51
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.65
Current Ratio0.14
Quick Ratio0.05
Book Value/Sh-0.04 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJan 18, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.221.01M
Float189.03M
Insiders13.12%
Institutions0.14%
Short Interest
Short Ratio0.3d
Short % Out.0.01%
Shares Short24.68K
Short (prev mo.)26.82K
Technical
SMA 500.0369 (-33.7%)
SMA 2000.0435 (-43.8%)
Beta0.70
S&P 52W Chg8.68%
Avg Vol (30d)92.72K
Avg Vol (10d)74.56K
Technical Indicators
RSI (14)31.5
MACD-0.0032
MACD Signal-0.0021
MACD Hist.-0.0011
BB Upper0.0405 USD
BB Middle0.0343 USD
BB Lower0.0280 USD
BB Width36.51%
ATR (14)0.0028 USD
Vol Ratio (20d)1.94x

About PharmaCielo (CVE: PCLO)

›

PharmaCielo (CVE: PCLO) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 0.0350 CAD on 20 November 2026, down 22.2% over 52 weeks. Its 52-week range is 0.0350 CAD to 0.1650 CAD, and it trades at the bottom of that range.

Its market capitalisation is 7.74M CAD.

PharmaCielo reports return on equity of 32.6%, an operating margin of -86.7% and revenue up 331.0% year over year.

Its debt exceeds its cash by 18.14M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 26 November 2026.